|
1.
|
Schrage YM, Briaire-De Bruijn IH, De
Miranda NF, et al: Kinome profiling of chondrosarcoma reveals
SRC-pathway activity and dasatinib as option for treatment. Cancer
Res. 69:6216–6222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Li X, Ye H, Cai L, et al: Millimeter wave
radiation induces apoptosis via affecting the ratio of Bax/Bcl-2 in
SW1353 human chondrosarcoma cells. Oncol Rep. 27:664–672.
2012.PubMed/NCBI
|
|
3.
|
Dickey ID, Rose PS, Fuchs B, et al:
Dedifferentiated chondrosarcoma: the role of chemotherapy with
updated outcomes. J Bone Joint Surg Am. 86:2412–2418.
2004.PubMed/NCBI
|
|
4.
|
Kalinski T, Sel S, Kouznetsova I, Röpke M
and Roessner A: Heterogeneity of angiogenesis and blood vessel
maturation in cartilage tumors. Pathol Res Pract. 205:339–345.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Yuan J, Dutton CM and Scully SP: RNAi
mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J
Orthop Res. 23:1467–1474. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Gelderblom H, Hogendoorn PC, Dijkstra SD,
et al: The clinical approach towards chondrosarcoma. Oncologist.
13:320–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Bovée JV, Cleton-Jansen AM, Taminiau AH
and Hogendoorn PC: Emerging pathways in the development of
chondrosarcoma of bone and implications for targeted treatment.
Lancet Oncol. 6:599–607. 2005.PubMed/NCBI
|
|
8.
|
Zuntini M, Salvatore M, Pedrini E, et al:
MicroRNA profiling of multiple osteochondromas: identification of
disease-specific and normal cartilage signatures. Clin Genet.
78:507–516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT:
MiR-138 induces cell cycle arrest by targeting cyclin D3 in
hepatocellular carcinoma. Carcinogenesis. 33:1113–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Anglicheau D, Muthukumar T and
Suthanthiran M: MicroRNAs: small RNAs with big effects.
Transplantation. 90:105–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
15.
|
Locatelli C, Filippin-Monteiro FB and
Creczynski-Pasa TB: Alkyl esters of gallic acid as anticancer
agents: a review. Eur J Med Chem. 60:233–239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Verma S, Singh A and Mishra A: Gallic
acid: molecular rival of cancer. Environ Toxicol Pharmacol.
35:473–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Kim YJ: Antimelanogenic and antioxidant
properties of gallic acid. Biol Pharm Bull. 30:1052–1055. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Panich U, Onkoksoong T, Limsaengurai S,
Akarasereenont P and Wongkajornsilp A: UVA-induced melanogenesis
and modulation of glutathione redox system in different melanoma
cell lines: the protective effect of gallic acid. J Photochem
Photobiol B. 108:16–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Shahrzad S, Aoyagi K, Winter A, Koyama A
and Bitsch I: Pharmacokinetics of gallic acid and its relative
bioavailability from tea in healthy humans. J Nutr. 131:1207–1210.
2001.PubMed/NCBI
|
|
20.
|
Zhang M, Zhou S, Zhang L, et al: miR-518b
is down-regulated, and involved in cell proliferation and invasion
by targeting Rap1b in esophageal squamous cell carcinoma. FEBS
Lett. 586:3508–3521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Liang W, Li X, Li C, et al:
Quercetin-mediated apoptosis via activation of the
mitochondrial-dependent pathway in MG-63 osteosarcoma cells. Mol
Med Rep. 4:1017–1023. 2011.PubMed/NCBI
|
|
22.
|
Kim HJ, Lee SG, Kim YJ, et al:
Cytoprotective role of autophagy during paclitaxel-induced
apoptosis in Saos-2 osteosarcoma cells. Int J Oncol. 42:1985–1992.
2013.PubMed/NCBI
|
|
23.
|
Kim SY and Helman LJ: Strategies to
explore new approaches in the investigation and treatment of
osteosarcoma. Cancer Treat Res. 152:517–528. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Russinoff S, Miran S, Gowda AL and Lucas
PA: Osteosarcoma cells differentiate into phenotypes from all three
dermal layers. Clin Orthop Relat Res. 469:2895–2904. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Liang CZ, Zhang X, Li H, et al: Gallic
acid induces the apoptosis of human osteosarcoma cells in vitro and
in vivo via the regulation of mitogen-activated protein kinase
pathways. Cancer Biother Radiopharm. 27:701–710. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Liao CL, Lai KC, Huang AC, et al: Gallic
acid inhibits migration and invasion in human osteosarcoma U-2 OS
cells through suppressing the matrix metalloproteinase-2/-9,
protein kinase B (PKB) and PKC signaling pathways. Food Chem
Toxicol. 50:1734–1740. 2012. View Article : Google Scholar
|
|
27.
|
Nagata S: Apoptosis by death factor. Cell.
88:355–365. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Circu ML and Aw TY: Reactive oxygen
species, cellular redox systems, and apoptosis. Free Radic Biol
Med. 48:749–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Du C, Fang M, Li Y, Li L and Wang X: Smac,
a mitochondrial protein that promotes cytochrome c-dependent
caspase activation by eliminating IAP inhibition. Cell. 102:33–42.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Danial NN and Korsmeyer SJ: Cell death:
critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Low IC, Kang J and Pervaiz S: Bcl-2: a
prime regulator of mitochondrial redox metabolism in cancer cells.
Antioxid Redox Signal. 15:2975–2987. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Del Gaizo Moore V and Letai A: BH3
profiling-measuring integrated function of the mitochondrial
apoptotic pathway to predict cell fate decisions. Cancer Lett.
332:202–205. 2013.PubMed/NCBI
|
|
33.
|
Fernández-Luna JL: Apoptosis regulators as
targets for cancer therapy. Clin Transl Oncol. 9:555–562. 2007.
|
|
34.
|
Lalier L, Cartron PF, Juin P, et al: Bax
activation and mitochondrial insertion during apoptosis. Apoptosis.
12:887–896. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Thorns C, Kuba J, Bernard V, et al:
Deregulation of a distinct set of microRNAs is associated with
transformation of gastritis into MALT lymphoma. Virchows Arch.
460:371–377. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Lima RT, Busacca S, Almeida GM, Gaudino G,
Fennell DA and Vasconcelos MH: MicroRNA regulation of core
apoptosis pathways in cancer. Eur J Cancer. 47:163–174. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Creighton CJ, Fountain MD, Yu Z, et al:
Molecular profiling uncovers a p53-associated role for microRNA-31
in inhibiting the proliferation of serous ovarian carcinomas and
other cancers. Cancer Res. 70:1906–1915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Cai CK, Zhao GY, Tian LY, et al: miR-15a
and miR-16-1 down-regulate CCND1 and induce apoptosis and cell
cycle arrest in osteosarcoma. Oncol Rep. 28:1764–1770.
2012.PubMed/NCBI
|
